Cambridge Study: Why Activating and Blocking the Same Receptor Both Aid Weight Loss
Health

Cambridge Study: Why Activating and Blocking the Same Receptor Both Aid Weight Loss

A Nature Metabolism study in mice traces GIP receptor agonists to the brainstem and antagonists to the hypothalamus, exp...

Noa Feldman 👁 42 💬 0
Novo Nordisk Shifts $600 Million U.S. Media Account to Omnicom
Companies

Novo Nordisk Shifts $600 Million U.S. Media Account to Omnicom

Danish drugmaker hands agency-of-record duties to Omnicom starting Q4 2026, moving from WPP’s Wavemaker as it doubles do...

Declan Byrne 👁 47 💬 0
Bank of America spends over $250 million on GLP-1 weight-loss drugs for its 210,000 employees
Companies

Bank of America spends over $250 million on GLP-1 weight-loss drugs for its 210,000 employees

CEO Brian Moynihan says the investment is “the right thing to do” even if some employees leave before seeing full health...

Declan Byrne 👁 27 💬 0